Biblio
Drug testing in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1. Clin Pharmacol Ther. 2019.
Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome. Clin Res Cardiol. 2019.
. .